Oncology Research Training Grant
Oncology Research Training Grant
批准号:
10712973
负责人:
Qing Li
金额:
$36.11万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
未结题
起止时间:
1980-07-01 至 2028-06-30
中文摘要
摘要
英文摘要
Abstract
The Oncology Research Training Program (ORTP) has been in existence for 40 years and was developed with
the primary goal of preparing physician-trainees (fellows in Adult Medical Oncology) for careers in academic
medicine. The rationale for training in oncology research is four fold: (a) Cancer remains one of the leading cause
of morbidity and mortality; (b) there is a need to maintain momentum that has been achieved in our fundamental
understanding of carcinogenesis, genomics and immunology (c) there is a need to translate progress gained in
the laboratory to the development of novel and better strategies for the diagnosis, therapies and prevention of
cancer and (d) in the rapidly chaniging health care advances and economics landscape, a critical need for
development of tools and policy to determine the most effective and efficient ways to deliver care and measure
outcomes in the society. The five Research training themes of the Program are carefully developed to build on
the past successes of training academic leaders. It melds emerging aspects of cancer biology, care and policy,
is aligned with the investigative interest and expertise of 44 established, extramurally-funded program faculty
members, leverages the outstanding resources of the Division of Hematology/Oncology, the Comprehensive
Cancer Center (UMCCC), the medical school and other units of the University of Michigan. The research training
themes are: (1) Molecular-genetic mechanisms of neoplastic transformation, aberrant signaling, and metastasis,
(2) Biomarkers in cancer prevention and therapy; (3) Molecular targets of drug discovery and experimental
therapuetics of cancer; (4) Immunological approaches to cancer therapy and (5) Health services research
focused on delivery, outcomes, reform and value. The trainees selected for this program will first experience
well-defined curriculum and training to the important concepts in the chosen research theme, and then spend 2-
3 years in the relevant laboratory and/ or clinical or health services research environment under the direct
supervision of a training program faculty mentor. The trainees will develop skills in: (a) to identify important
questions in oncology research (b) develop testable hypotheses that will address the pertinent questions (c)
aquire the necessary technical expertise to rigorously test the hypotheses identified; (d) critically evaluate the
data generated; (e) develop the necessary skills of written and oral communication to promulgate the conclusions
made and (f) develop and compete of peer-reviewed grants. The trainees will have an MD or MD-PhD degree,
completed residency training in Internal Medicine and a year of clinical subspecialty training in ADULT medical
oncology/hematology. The ultimate goal of the program is to prepare trainees for careers in academic oncology
as independent faculty members in schools of medicine at research universities.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s11523-017-0526-1
发表时间:
2017-12
期刊:
Targeted oncology
影响因子:
5.4
作者:
[Qin A, Gadgeel S]
通讯作者:
Gadgeel S
A phase I-II trial of cisplatin and dichloromethotrexate in squamous cell cancer of the head and neck.
顺铂和二氯甲氨蝶呤治疗头颈部鳞状细胞癌的 I-II 期试验。
DOI:
10.1200/jco.1984.2.7.831
发表时间:
1984
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
[Wheeler,RH, Natale,RB, Roshon,SG, Baker,SR]
通讯作者:
Baker,SR
Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation.
使用单克隆抗体对早期人类黑色素瘤集落进行免疫过氧化物酶染色。
DOI:
--
发表时间:
1984
期刊:
The American journal of pathology
影响因子:
--
作者:
[Nakano,GM, Natale,RB, Lobuglio,AF, Houghton,AN]
通讯作者:
Houghton,AN
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
在晚期胰腺癌中,卡培他滨和放射治疗之前和之后进行联合化疗。
DOI:
10.1016/j.ijrobp.2005.04.030
发表时间:
2005
期刊:
International journal of radiation oncology, biology, physics
影响因子:
--
作者:
[Schneider,BryanJ, Ben-Josef,Edgar, McGinn,CorneliusJ, Chang,AlfredE, Colletti,LisaM, Normolle,DanielP, Hejna,GwenF, Lawrence,TheodoreS, Zalupski,MarkM]
通讯作者:
Zalupski,MarkM
DOI:
10.1002/cam4.819
发表时间:
2016-09
期刊:
CANCER MEDICINE
影响因子:
4
作者:
[Qin, Angel, Coffey, David G., Warren, Edus H., Ramnath, Nithya]
通讯作者:
Ramnath, Nithya
共 13 条
The role of ER associated degradation (ERAD) in hematopoietic stem cells
-
批准号:10187650
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2020
-
负责人:Qing Li
-
依托单位:
The role of ER associated degradation (ERAD) in hematopoietic stem cells
-
批准号:10454963
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2020
-
负责人:Qing Li
-
依托单位:
The role of ER associated degradation (ERAD) in hematopoietic stem cells
-
批准号:10649697
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2020
-
负责人:Qing Li
-
依托单位:
Oncogenic Nras signaling in leukemic stem cell transformation
-
批准号:9028457
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:Qing Li
-
依托单位:
Oncogenic Nras signaling in leukemic stem cell transformation
-
批准号:9234062
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:Qing Li
-
依托单位:
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
-
批准号:7923173
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2008
-
负责人:Qing Li
-
依托单位:
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
-
批准号:7509983
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2008
-
负责人:Qing Li
-
依托单位:
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
-
批准号:8332887
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2008
-
负责人:Qing Li
-
依托单位:
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
-
批准号:7681712
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2008
-
负责人:Qing Li
-
依托单位:
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
-
批准号:8116544
-
项目类别:
-
资助金额:$12.72万
-
财政年份:2008
-
负责人:Qing Li
-
依托单位:
Oncology Research Training Grant
-
批准号:10412056
-
项目类别:
-
资助金额:$37.39万
-
财政年份:1980
-
负责人:Qing Li
-
依托单位:
海外基金